Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about VIM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
VIM is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, biomarker for. Associated with ALS, Aging, Als. Connected to 209 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | VIM |
| Full Name | Vimentin |
| Chromosome | 10p13 |
| Function | encodes a type III intermediate filament protein that is one of the most widely expressed structural proteins in eukaryotic cells. |
| Subcellular Localization | </th><td>Cytoplasm, intermediate filaments, perinuclear region</td></tr> |
| Molecular Weight | 57 kDa |
| Amino Acids | 466 aa |
| Exons | 9 |
| Pathways | Autophagy, Immune Response, Mapk, Notch Signaling, Proteasome |
| Ensembl ID | ENSG00000026025 |
| OMIM | 193060 |
| GeneCards | VIM |
| Human Protein Atlas | VIM |
| Length | 466 amino acids |
| Molecular weight | ~54 kDa |
| Associated Diseases | Diabetes, Inflammation, Parkinson, Parkinson's disease |
| Known Drugs/Compounds | Columbianadin, rapamycin |
| Interactions | ACTB, AMPK, AND, ANXA2, AQP4, AR |
| KG Connections | 377 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
VIM["VIM
(Vimentin)"]
%% Autophagy pathway
BECN1["BECN1
(Beclin-1)"]
MAP1LC3B["MAP1LC3B
(LC3B)"]
ATG14["ATG14
(Autophagy Protein)"]
PIK3C3["PIK3C3
(VPS34)"]
UVRAG["UVRAG
(Autophagy Regulator)"]
LAMP1["LAMP1
(Lysosomal Protein)"]
Autophagy["Autophagy
Pathway"]
%% Protein degradation
UPS["Ubiquitin-Proteasome
System"]
HDAC6["HDAC6
(Histone Deacetylase)"]
%% Cellular stress
H2AX["H2AX
(DNA Damage Marker)"]
MAP3K5["MAP3K5
(ASK1 Kinase)"]
%% Disease outcomes
Inflammation["Neuroinflammation"]
Senescence["Cellular
Senescence"]
ALS["Amyotrophic Lateral
Sclerosis (ALS)"]
PD["Parkinson's
Disease"]
MS["Multiple
Sclerosis"]
%% Connections
VIM -->|"regulates"| BECN1
VIM -->|"regulates"| ATG14
VIM -->|"regulates"| Autophagy
VIM -->|"associated with"| MAP1LC3B
VIM -->|"associated with"| PIK3C3
VIM -->|"associated with"| UVRAG
VIM -->|"associated with"| LAMP1
VIM -->|"regulates"| UPS
VIM -->|"associated with"| HDAC6
VIM -->|"regulates"| H2AX
VIM -->|"associated with"| MAP3K5
BECN1 -->|"initiates"| Autophagy
ATG14 -->|"promotes"| Autophagy
MAP1LC3B -->|"mediates"| Autophagy
PIK3C3 -->|"activates"| Autophagy
UVRAG -->|"regulates"| Autophagy
LAMP1 -->|"completes"| Autophagy
VIM -->|"biomarker for"| Inflammation
VIM -->|"biomarker for"| Senescence
VIM -->|"biomarker for"| ALS
VIM -->|"therapeutic target"| PD
VIM -->|"therapeutic target"| MS
H2AX -->|"indicates"| Senescence
MAP3K5 -->|"promotes"| Inflammation
%% Styling
style VIM fill:#006494
style Autophagy fill:#1b5e20
style UPS fill:#1b5e20
style BECN1 fill:#4a1a6b
style ATG14 fill:#4a1a6b
style HDAC6 fill:#4a1a6b
style Inflammation fill:#ef5350
style Senescence fill:#ef5350
style ALS fill:#5d4400
style PD fill:#5d4400
style MS fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Notch Signaling | regulates | pathway | 0.90 |
| Synoviocyte Migration | promotes | phenotype | 0.85 |
| VAV2 | activates | gene | 0.85 |
| Synoviocyte Invasion | promotes | phenotype | 0.85 |
| neurodegeneration | involved_in | process | 0.75 |
| Aging | biomarker_for | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Fibrosis | biomarker_for | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Inflammation | biomarker_for | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Senescence | biomarker_for | disease | 0.65 |
| Longevity | biomarker_for | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| ALS | biomarker_for | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Breast Cancer | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Prostate Cancer | inhibits | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Diabetes | associated_with | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| PARKINSON | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| Chaperone | inhibits | pathway | 0.60 |
| Metastasis | inhibits | pathway | 0.60 |
| DIABETES MELLITUS | associated_with | gene | 0.60 |
| Lysosomal Degradation | activates | pathway | 0.60 |
| Jak-Stat | inhibits | pathway | 0.60 |
| Immune Response | regulates | pathway | 0.60 |
| DENND3 | associated_with | gene | 0.60 |
| MGA | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Columbianadin | inhibits | compound | 0.95 |
| Columbianadin | binds | compound | 0.90 |
| GFAP | associated_with | protein | 0.85 |
| SCIN | activates | gene | 0.60 |
| TJP1 | activates | gene | 0.60 |
| CX43 | biomarker_for | gene | 0.60 |
| GSH | biomarker_for | gene | 0.60 |
| CX43 | expressed_in | gene | 0.60 |
| FGF21 | activates | gene | 0.60 |
| APP | biomarker_for | gene | 0.60 |
| FNDC5 | activates | gene | 0.60 |
| S100B | biomarker_for | gene | 0.60 |
| PLAU | activates | gene | 0.60 |
| CXCL10 | activates | gene | 0.60 |
| C1Q | biomarker_for | gene | 0.60 |
| CX3CL1 | activates | gene | 0.60 |
| SOD2 | associated_with | gene | 0.60 |
| CDC42 | associated_with | gene | 0.60 |
| CYCS | associated_with | gene | 0.60 |
| RAC1 | therapeutic_target | gene | 0.60 |
| MET | therapeutic_target | gene | 0.60 |
| MMP9 | associated_with | gene | 0.60 |
| MMP9 | regulates | gene | 0.60 |
| GADD45A | regulates | gene | 0.60 |
| MAPK14 | regulates | gene | 0.60 |
| AQP4 | activates | gene | 0.60 |
| TLR6 | activates | gene | 0.60 |
| GFAP | activates | gene | 0.60 |
| IL1B | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| PROGRANULIN | activates | gene | 0.60 |
| TPM2 | associated_with | gene | 0.60 |
| LAMP1 | associated_with | gene | 0.60 |
| HDAC6 | associated_with | gene | 0.60 |
| VIMENTIN | associated_with | gene | 0.60 |
| LDH | biomarker_for | gene | 0.60 |
| TNF | biomarker_for | gene | 0.60 |
| CD31 | regulates | gene | 0.60 |
| CKB | regulates | gene | 0.60 |
| CTS | regulates | gene | 0.60 |
| GATA3 | regulates | gene | 0.60 |
| GLB1 | regulates | gene | 0.60 |
| IL1RL1 | regulates | gene | 0.60 |
| IL4 | regulates | gene | 0.60 |
| IL7R | regulates | gene | 0.60 |
| LC3 | regulates | gene | 0.60 |
| LDH | regulates | gene | 0.60 |
| PECAM1 | regulates | gene | 0.60 |
| RORC | regulates | gene | 0.60 |
| SQSTM1 | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning VIM in their description or question text
No additional research found